Their findings emphasized the GLP-1 receptor’s direct impact on periodontitis therapy, instead of its effects on decreasing blood sugar and preventing obesity [37]. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.